Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2019

Open Access 01-12-2019 | Care | Research article

Medical oncology outpatients’ preferences and experiences with advanced care planning: a cross-sectional study

Authors: Amy Waller, Heidi Turon, Jamie Bryant, Alison Zucca, Tiffany-Jane Evans, Rob Sanson-Fisher

Published in: BMC Cancer | Issue 1/2019

Login to get access

Abstract

Background

Medical oncology outpatients are a group for whom advance care planning (ACP) activities are particularly relevant. Patient views can help prioritise areas for improving end of life communication. The study aimed to determine in a sample of medical oncology outpatients: (1) the perceived importance of participating in ACP activities; (2) the proportion of patients who have ever participated in ACP activities; and (3) the proportion of patients who had not yet participated in ACP activities who were willing to do so in next month.

Methods

Adult medical oncology outpatients in two Australian cancer treatment centres were consecutively approached to complete a pen-and-paper survey. Items explored perceived importance, previous participation, and willingness to participate across key ACP activities including: discussing wishes with their family or doctor; recording wishes in a written document; appointing a substitute decision maker (SDM); and discussing life-expectancy.

Results

185 participants completed the survey (51% consent rate). Most patients agreed it was important to: discuss end of life wishes with family (85%) and doctors (70%) and formally record wishes (73%). Few had discussed end of life wishes with a doctor (11%), recorded their wishes (15%); chosen a SDM (28%); discussed life expectancy (30%); or discussed end of life wishes with family (30%). Among those who had not participated in ACP, most were willing to discuss life expectancy (66%); discuss end of life wishes with family (57%) and a doctor (55%); and formally record wishes (56%) in the next month. Fewer wanted to appoint a SDM (40%).

Conclusion

Although medical oncology outpatients perceive ACP activities are important, rates of uptake are relatively low. The willingness of many patients to engage in ACP activities suggests a gap in current ACP practice. Efforts should focus on ensuring patients and families have clarity about the legal and other ramifications of ACP activities, and better education and training of health care providers in initiating conversations about end of life issues.
Literature
1.
2.
Institute of Medicine: Crossing the quality chasm: A new health system for the 21st century. 2001.
3.
Barbera L, Seow H, Sutradhar R, Chu A, Burge F, Fassbender K, McGrail K, Lawson B, Liu Y, Pataky R, et al. Quality indicators of end-of-life Care in Patients with Cancer: what rate is right? J Oncol Pract. 2015;11(3):e279–87.PubMedCrossRef
4.
Earle CC, Park ER, Lai B, Weeks JC, Ayanian JZ, Block S. Identifying potential indicators of the quality of end-of-life Cancer care from administrative data. J Clin Oncol. 2003;21(6):1133–8.PubMedCrossRef
5.
Virdun C, Luckett T, Lorenz KA, Phillips J: National quality indicators and policies from 15 countries leading in adult end-of-life care: a systematic environmental scan. BMJ Support Palliat Care. 2018; 8:145–54.
6.
Dartmouth Institute for Health Policy and Clinical Practice: Trends in Cancer Care Near the End of Life. 2013.
7.
Rochigneux P, Raoul JL, Beaussant Y, Aubry R, Goldwasser F, Tournigand C, Morin L. Use of chemotherapy near the end of life: what factors matter? Ann Oncol. 2017;28(4):809–17.PubMed
8.
Chen RC, Falchook AD, Tian F, Basak R, Hanson L, Selvam N, Dusetzina S. Aggressive care at the end-of-life for younger patients with cancer: Impact of ASCO's Choosing Wisely campaign. J Clin Oncol. 2016;34(18_suppl):LBA10033.CrossRef
9.
Cardona-Morrell M, Benfatti-Olivato G, Jansen J, Turner RM, Fajardo-Pulido D, Hillman K. A systematic review of effectiveness of decision aids to assist older patients at the end of life. Patient Educ Couns. 2017;100(3):425–35.PubMedCrossRef
10.
Cardona-Morrell M, Kim JCH, Brabrand M, Gallego-Luxan B, Hillman K. What is inappropriate hospital use for elderly people near the end of life? A systematic review. Eur J Intern Med. 2017;42:39–50.PubMedCrossRef
11.
Langton JM, Reeve R, Srasuebkul P, Haas M, Viney R, Currow D, Pearson SA. Health service use and costs in the last 6 months of life in elderly decedents with a history of cancer: a comprehensive analysis from a health payer perspective. Br J Cancer. 2016;114(11):1293–302.PubMedPubMedCentralCrossRef
12.
Sudore RL, Lum HD, You JJ, Hanson LC, Meier DE, Pantilat SZ, Matlock DD, Rietjens JAC, Korfage IJ, Ritchie CS, et al. Defining Advance Care Planning for Adults: A Consensus Definition from a Multidisciplinary Delphi Panel. J Pain Symptom Manage. 2017;53(5):821–32 e821.PubMedPubMedCentralCrossRef
13.
Sudore RL, Heyland DK, Lum HD, Rietjens JAC, Korfage IJ, Ritchie CS, Hanson LC, Meier DE, Pantilat SZ, Lorenz K, et al. Outcomes that define successful advance care planning: a Delphi panel consensus. J Pain Symptom Manag. 2017; 55(2):245–55.e8.
14.
Brinkman-Stoppelenburg A, Rietjens JA, van der Heide A. The effects of advance care planning on end-of-life care: a systematic review. Palliat Med. 2014;28(8):1000–25.PubMedCrossRef
15.
Detering KM, Hancock AD, Reade MC, Silvester W. The impact of advance care planning on end of life care in elderly patients: randomised controlled trial. BMJ. 2010;340:c1345.PubMedPubMedCentralCrossRef
16.
Wright AA, Zhang B, Ray A, Mack JW, Trice E, Balboni T. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008;300(14):1665–73.
17.
Mack JW, Weeks JC, Wright AA, Block SD, Prigerson HG. End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences. J Clin Oncol. 2010;28(7):1203–8.PubMedPubMedCentralCrossRef
18.
Narang AK, Wright AA, Nicholas LH. Trends in advance care planning in patients with Cancer: results from a National Longitudinal Survey. JAMA Oncol. 2015;1(5):601–8.PubMedPubMedCentralCrossRef
19.
Mack JW, Cronin A, Taback N, Huskamp HA, Keating NL, Malin JL, Earle CC, Weeks JC. End-of-life discussions among patients with advanced cancer: a cohort study. Ann Intern Med. 2012;156(3):204–10.PubMedPubMedCentralCrossRef
20.
Bestvina CM, Polite BN. Implementation of advance care planning in oncology: a review of the literature. J Oncol Pract. 2017;13(10):657–62.PubMedCrossRef
21.
Johnson S, Butow P, Kerridge I, Tattersall M. Advance care planning for cancer patients: a systematic review of perceptions and experiences of patients, families, and healthcare providers. Psychooncology. 2016;25(4):362–86.PubMedCrossRef
22.
You JJ, Downar J, Fowler RA, Lamontagne F, Ma IW, Jayaraman D, Kryworuchko J, Strachan PH, Ilan R, Nijjar AP, et al. Barriers to goals of care discussions with seriously ill hospitalized patients and their families: a multicenter survey of clinicians. JAMA Intern Med. 2015;175(4):549–56.PubMedCrossRef
23.
Lund S, Richardson A, May C. Barriers to advance care planning at the end of life: an explanatory systematic review of implementation studies. PLoS One. 2015;10(2):e0116629.PubMedPubMedCentralCrossRef
24.
Teno JM, Price RA, Makaroun LK. (2017). Challenges of measuring quality of community-based programs for seriously ill individuals and their families. Health Affairs. 2017;36(7):1227–33.
25.
Carey M, Sanson-Fisher R, Clinton-McHarg T, Boyes A, Olver I, Oldmeadow C, Paul C, D'Este C, Henskens F. Examining variation across treatment clinics in cancer patients' psychological outcomes: results of a cross sectional survey. Support Care Cancer. 2018;26(9):3201–8.
26.
Barnes KA, Barlow CA, Harrington J, Ornadel K, Tookman A, King M, Jones L. Advance care planning discussions in advanced cancer: analysis of dialogues between patients and care planning mediators. Palliat Support Care. 2011;9(1):73–9.PubMedCrossRef
27.
Kuluski K, Gill A, Naganathan G, Upshur R, Jaakkimainen RL, Wodchis WP. A qualitative descriptive study on the alignment of care goals between older persons with multi-morbidities, their family physicians and informal caregivers. BMC Fam Pract. 2013;14:133.PubMedPubMedCentralCrossRef
28.
Weeks JC, Catalano PJ, Cronin A, Finkelman MD, Mack JW, Keating NL, Schrag D. Patients' expectations about effects of chemotherapy for advanced cancer. N Engl J Med. 2012;367(17):1616–25.PubMedPubMedCentralCrossRef
29.
Waller A, Sanson-Fisher R, Zdenkowski N, Douglas C, Hall AE, Walsh J. The right place at the right time: medical oncology outpatients' perceptions of location of end of life care. JNCCN. 2018;16:35–41
30.
Australian Health Ministers’ Advisory Council: National Advance Care Directives Working Group. A National Framework for Advance Care Directives. Canberra; 2011.
31.
Rietjens JAC, Sudore RL, Connolly M, van Delden JJ, Drickamer MA, Droger M, van der Heide A, Heyland DK, Houttekier D, Janssen DJA, et al. Definition and recommendations for advance care planning: an international consensus supported by the European Association for Palliative Care. Lancet Oncol. 2017;18(9):e543–51.PubMedCrossRef
32.
White B, Willmott L, Tilse C, Wilson J, Lawson D, Pearce A, Dunn J, Aitken JF, Feeney R, Jowett S: Community knowledge of law at the end of life: availability and accessibility of web-based resources. Aust Health Rev 2018;42(3):266-71. 
33.
Flo E, Husebo BS, Bruusgaard P, Gjerberg E, Thoresen L, Lillemoen L, Pedersen R. A review of the implementation and research strategies of advance care planning in nursing homes. BMC Geriatr. 2016;16:24.PubMedPubMedCentralCrossRef
34.
Koss CS. Beyond the individual: the interdependence of advance directive completion by older married adults. J Am Geriatr Soc. 2017;65(7):1615–20.PubMedCrossRef
35.
Bernacki RE, Block SD. Communication about serious illness care goals: a review and synthesis of best practices. JAMA Intern Med. 2014;174(12):1994–2003.PubMedCrossRef
36.
Hammes BJ, Rooney BL. Death and end-of-life planning in one midwestern community. Arch Intern Med. 1998;158(4):383–90.PubMedCrossRef
37.
Schmidt TA, Zive D, Fromme EK, Cook JN, Tolle SW. Physician orders for life-sustaining treatment (POLST): lessons learned from analysis of the Oregon POLST registry. Resuscitation. 2014;85(4):480–5.PubMedCrossRef
38.
Waller A, Douglas C, Sanson-Fisher R, Zdenkwoski N, Pearce A, Evans T, Walsh J. Dances with denial: have medical oncology outpatients conveyed their end of life wishes and do they want to? JNCCN. 2018;16:498-505
39.
Enzinger AC, Zhang B, Schrag D, Prigerson HG. Outcomes of prognostic disclosure: associations with prognostic understanding, distress, and relationship with physician among patients with advanced Cancer. J Clin Oncol. 2015;33(32):3809–16.PubMedPubMedCentralCrossRef
40.
Cardona M, Kellett J, Lewis E, Brabrand M, Ni Chroinin D: Truth disclosure on prognosis: Is it ethical not to communicate personalised risk of death? Int J Clin Pract 2018;72(8):e13222. 
41.
Zucca AC, Sanson-Fisher RW, Waller A, Carey M, Grady A, Mackenzie L. Life expectancy discussions in a multisite sample of Australian medical oncology outpatients. Med J Aust. 2015;203(10):405.PubMedCrossRef
Metadata
Title
Medical oncology outpatients’ preferences and experiences with advanced care planning: a cross-sectional study
Authors
Amy Waller
Heidi Turon
Jamie Bryant
Alison Zucca
Tiffany-Jane Evans
Rob Sanson-Fisher
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Care
Published in
BMC Cancer / Issue 1/2019
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-019-5272-6

Other articles of this Issue 1/2019

BMC Cancer 1/2019 Go to the issue

Research article

Functional role of SGK3 in PI3K/Pten driven liver tumor development

Research article

Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study

Research article

Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumours

Research article

Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma – correlation with clinicopathological data and comparison of antibodies

Research article

Gene signature characteristic of elevated stromal infiltration and activation is associated with increased risk of hematogenous and lymphatic metastasis in serous ovarian cancer

Research article

Incidence of thyroid cancer in Puerto Rico and the US by racial/ethnic group, 2011–2015
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits